Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Urologia Internationalis|July 12, 2014
Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomyTobias Maurer, Thomas Horn, Michael Souvatzoglou, et al.Cancer Research|July 20, 2006
Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agentsKlaus Mantwill, Nadia Köhler-Vargas, Alexandra Bernshausen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findingsMaria Picchio, Uwe Treiber, Ambros J Beer, et al.Journal of Hematology & Oncology|March 7, 2014
Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancerMark Thalgott, Thomas Horn, Matthias M Heck, et al.Cancer|April 29, 2009
A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinomaChristian Wülfing, Jean-Pascal H Machiels, Dirk J Richel, et al.European Urology|December 27, 2011
Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomyTobias Maurer, Michael Souvatzoglou, Hubert Kübler, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2016
Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancerSarah M Schwarzenböck, Matthias Eiber, Günther Kundt, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2014
11C-Choline PET/pathology image coregistration in primary localized prostate cancerAnca-Ligia Grosu, Gregor Weirich, Christina Wendl, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 8, 2013
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimensRalph A Bundschuh, Christina M Wendl, Gregor Weirich, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2010
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft modelBernd J Krause, Michael Souvatzoglou, Ken Herrmann, et al.Pageof 3